Insurance Brokerage Tender
1. Independent professional insurance brokerage services and assistance with insurance coverage to meet the demands and needs of the Agency.
United Kingdom-London: Insurance brokerage service – EMA/2015/30/IS
2015/S 154-283317
Contract notice
Services
Directive 2004/18/EC
Section I: Contracting authority
I.1)Name, addresses and contact point(s)
European Medicines Agency
30 Churchill Place, Canary Wharf
For the attention of: Mr Jacek Ellmann
E14 5EU London
UNITED KINGDOM
E-mail: insurance@ema.europa.eu
Internet address(es):
General address of the contracting authority: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000259.jsp&mid=WC0b01ac0580029487
Address of the buyer profile: http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000259.jsp&mid=WC0b01ac0580029487
Electronic access to information: https://etendering.ted.europa.eu/cft/cft-display.html?cftId=1016
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
I.2)Type of the contracting authority
I.3)Main activity
I.4)Contract award on behalf of other contracting authorities
Section II: Object of the contract
II.1.1)Title attributed to the contract by the contracting authority:
II.1.2)Type of contract and location of works, place of delivery or of performance
Service category No 6: Financial services a) Insurances services b) Banking and investment services
Main site or location of works, place of delivery or of performance: European Medicines Agency (EMA), 30 Churchill Place, Canary Wharf, London, E14 5EU, UNITED KINGDOM.
NUTS code UKI12
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
II.1.5)Short description of the contract or purchase(s)
2. Placement and renewal of Agency’s insurances with suitable insurance providers, at all times ensuring such placements are contract certain.
3. Ongoing management and administration of Agency insurance coverage.
4. Liaising with the Agency appointed insurance advisor to ensure the Agency’s interests are adequately protected.
5. Claims handling and management services.
II.1.6)Common procurement vocabulary (CPV)
66518000
II.1.7)Information about Government Procurement Agreement (GPA)
II.1.8)Lots
II.1.9)Information about variants
II.2.1)Total quantity or scope:
Note: Estimated value of insurance premiums is 1 500 000 EUR.
The Agency may exercise the option to increase the estimated contract volume at a later stage by negotiated procedure with the successful tenderer in accordance with Article 134(1)(f) of the rules of application of the general Financial Regulation.
II.2.2)Information about options
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion
Section III: Legal, economic, financial and technical information
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
III.1.4)Other particular conditions
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
III.2.3)Technical capacity
All information required is indicated in the technical specifications which can be downloaded using the link to the ‘Electronic access to information’ in point I.1 of this notice.
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service
Section IV: Procedure
IV.1.1)Type of procedure
IV.2.1)Award criteria
IV.2.2)Information about electronic auction
IV.3.1)File reference number attributed by the contracting authority:
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up
Other: The Agency will accept documentation in any EU language. The Agency prefers, however, to receive all documentation in English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening of tenders
Date: 22.9.2015 – 9:30
Place:
European Medicines Agency, 30 Churchill Place, Canary Wharf, London, E14 5EU, UNITED KINGDOM.
Persons authorised to be present at the opening of tenders: yes
Additional information about authorised persons and opening procedure: Maximum of 1 representative per tenderer is permitted to be present at the opening. For security reasons, tenderers must register within the given deadline (please see the invitation to tender letter) to be allowed to attend the opening session.
Section VI: Complementary information
VI.1)Information about recurrence
Estimated timing for further notices to be published: 4 years.
VI.2)Information about European Union funds
VI.3)Additional information
VI.4.1)Body responsible for appeal procedures
General Court
rue du Fort Niedergrünewald
2925 Luxembourg
LUXEMBOURG
E-mail: generalcourt.registry@curia.europa.eu
Telephone: +352 4303-1
Internet address: http://curia.europa.eu
Fax: +352 4303-2100
VI.4.2)Lodging of appeals
Precise information on deadline(s) for lodging appeals: You may submit any observations concerning the award procedure to the contracting authority indicated under heading I.1.
If you believe that there was maladministration, you may lodge a complaint to the European Ombudsman within 2 years of the date when you became aware of the facts on which the complaint is based (see http://www.ombudsman.europa.eu). Such complaint does not have as an effect either to suspend the time limit to launch an appeal or to open a new period for lodging an appeal.
Within 2 months of the notification of the award decision you may lodge an appeal to the body referred to in VI.4.1.
VI.4.3)Service from which information about the lodging of appeals may be obtained
European Medicines Agency
30 Churchill Place
E14 5EU London
UNITED KINGDOM
E-mail: info@ema.europa.eu
Telephone: +44 2036606000
Internet address: http://www.ema.europa.eu/ema/
Fax: +44 2036605555
VI.5)Date of dispatch of this notice: